期刊文献+

社区HIV病毒载量可作为人群病毒载量最优替代指标

Community viral load-an optimal alternative index of population viral load for HIV/AIDS surveillance
原文传递
导出
摘要 目的探讨适用于评估新疆伊宁市HIV传播潜力的人群病毒载量(PVL)最优替代指标。方法建立动态队列研究,监测伊宁市2017—2019年所有HIV/AIDS的病毒载量(VL),计算不同PVL替代指标值,并评估不同PVL替代指标、病毒血症流行率与HIV新发感染率、抗逆转录病毒治疗(ART)覆盖率、病毒抑制率的关联强度。结果新疆伊宁市2017—2019年HIV感染者的不同PVL指标值均呈逐年下降趋势(P<0.05),社区病毒载量(CVL)的减少与HIV新发感染率的增加之间显著相关(r=0.999,P=0.028),CVL与ART覆盖率(r=-1.000,P=0.001)、病毒抑制率(r=-1.000,P=0.010)均呈负相关。以不同VL值为界限的敏感性分析中的病毒血症流行率2(VL>400 copies/mL)和病毒血症流行率3(VL>1000 copies/mL)与HIV新发感染率呈正相关(r^(2)=0.997,P^(2)=0.048;r^(3)=0.998,P^(3)=0.041),与ART覆盖率(r^(2)=-1.000,P^(2)=0.019;r^(3)=-1.000,P^(3)=0.012)、病毒抑制率(r^(2)=-1.000,P^(2)=0.010;r^(3)=-1.000,P^(3)=0.003)均呈负相关。结论CVL为PVL最优替代指标,可与病毒血症流行率共同评估新疆伊宁市HIV传播潜力。 Objective To explore an optimal alternative index of population viral load(PVL)suitable for assessing potential human immunodeficiency virus(HIV)transmission in the population of Yining city,Xinjiang Uygur Autonomous Region.Methods All previously and newly diagnosed HIV/AIDS cases aged≥13 years were recruited into a dynamic cohort in Yining city from 2017 through 2019.Questionnaire interviews and viral load(VL)monitoring were conducted among all the HIV/AIDS cases.Based on the data collected,PVL,monitored viral load(MVL),in-care viral load(ICVL),aware viral load(AVL),and community viral load(CVL)were calculated and viremia prevalence,HIV infection incidence,antiretroviral therapy(ART)coverage,and viral inhibition rate were estimated.Correlations among the indicators were assessed.Results All values of PVL,MVL,ICVL,and AVL decreased significantly during the 3-year period(all P<0.05).The decrease in CVL were significantly correlated with the increase in HIV infection incidence(r=0.999,P=0.028).The CVL is inversely correlated with ART coverage(r=-1.000,P=0.001)and virus inhibition rate(r=-1.000,P=0.010).The viremia prevalence rates with specific VL cut-off values were significantly correlated positively with HIV infection incidence(for VL>400 copies/m:r=0.997,P=0.048 and for VL>1000 copies/mL:r=0.998,P=0.041)but inversely with ART coverage(r=-1.000,P=0.019 and r=-1.000,P=0.012)and virus suppression rate(r=-1.000,P=0.010 and r=-1.000,P=0.003).Conclusion CVL is the most optimal alternative index of PVL and could be adopted together with viremia prevalence rate in assessment on potential HIV transmission intensity.
作者 何倩 艾孜买提·艾克拜尔 胡晓敏 倪祯 曾长玉 倪明健 HE Qian;Aizimaiti·Aikebaier;HU Xiao-min(School of Public Health,Xinjiang Medical University,Urumqi,Xinjiang Uygur Autonomous Region 830011,China;不详)
出处 《中国公共卫生》 CSCD 北大核心 2022年第6期766-770,共5页 Chinese Journal of Public Health
基金 国家科技重大专项(2018ZX10715-007) 新疆艾滋病防控研究重点实验室(XJYS1706)。
关键词 艾滋病毒/艾滋病 人群病毒载量 社区病毒载量 病毒血症流行率 新发感染率 HIV/AIDS population viral load community viral load viremia prevalence new infection rate
  • 相关文献

参考文献2

二级参考文献21

  • 1于兰,豆智慧,曲淑霞,张福杰,文毅,赵燕.HAART药物依从性对CD_4细胞增长率的影响研究[J].中国艾滋病性病,2005,11(4):255-257. 被引量:15
  • 2凌雪梅,欧阳丽华,邓晓军,欧玉梅.46例HIV感染者/AIDS患者高效抗逆转录病毒疗法的效果分析[J].实用预防医学,2007,14(2):556-558. 被引量:10
  • 3国家免费艾滋病HAART药物治疗手册(第三版)[M].人民卫生出版社,2012,13,45-46,8589,133-135,141.
  • 4Antiretroviral therapy for" HIV infection in adults and adoles- cents: Recommendation for a public health approach (2010 revi- sion)[-M. World Health Organization, 2010, 50--51.
  • 5Jason T Blaekard, Sethl, Welles, Avraackerman, et al. Immuno- logical rebound after initiation of highly active antiretroviral thera- py in treatment-naive patients[J]. AIDS Research and Human Retroviruses, 2008, 24(3):499--504.
  • 6汪习成,吴昊.艾滋病初始HAART治疗新进展[J].国际流行病传染病学杂志,2006,33(1):52-54.
  • 7SH Mehta, G Lucas, J Astemborski, et al. Early immunologic virologic responses to highly active antiretroviral therapy and sub- sequent disease progression among HIV-infected injection drug users[J]. AIDS Care, 2007, 19(5) ..637--645.
  • 8Amy Knowlton, Julia Arnsten, Lois Eldred, et al. Individual,interpersonal, and structural correlates of effective HAART use among urban active injection drug users[J]. Acquir Immune DefieSyndr, 2006, 41:486 492.
  • 9Christian Pradier, Patrizia Carrieri, Laurence Bentz, et al. Im- pact of short-term adherence on virological and immunological success of HAART: A case study among French HIV-infection IDUs[J]. International Journal of STD and AIDS, 2001, 12: 324--328.
  • 10Ma Y, Zhao DC, Yu L, et al. Predictors of virologic failure in HIV-l-infected adults receiving first-line antiretroviral therapy in 8 provinces in China[J]. Clinical Infectious Diseases, 2010, 50, 264 271.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部